Vogue Commercial Co. Ltd Live Quote-Cohance Lifesciences Ltd | BFSL

COHANCE LIFESCIENCES LTD.

  • NSE CodeCOHANCEEQ
  • BSE Code543064
  • ISININE03QK01018
  • IndustryPharmaceuticals

Company Information

Management

Mr. Himanshu Agarwal

Chief Financial Officer

Dr. Sudhir Kumar Singh

Chief Executive Officer

Mr. Gaurav Bahadur

Chief Human Resource Officer

Mr. Kundan Kumar Jha

Head - Legal & Co. Secretary

Incorporation Year

06/11/2018

Registered Address

Registered Office : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala MIDC,
Mumbai, Maharashtra - 400093
Tel: 022-61539999
Fax: 022-23541152

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

info@suvenpharm.com

Website

http://www.suvenpharm.com

Listing

BSE, BSE, NSE

Corporate News

Cohance Lifesciences - Clarification With Respect To ...

13-Apr-2026|5:56PM

Clarification with respect to Volume Movement

Cohance Lifesciences - Clarification sought from Coha...

13-Apr-2026|4:10PM

The Exchange has sought clarification from Cohance Lifesciences Ltd on Apri

Cohance Lifesciences - Spurt in Volume

12-Apr-2026|11:45PM

Significant increase in volume has been observed in Cohance Lifesciences Li

Cohance Lifesciences - Spurt in Volume

10-Apr-2026|7:29PM

Significant increase in volume has been observed in Cohance Lifesciences Li

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug81.08229.90
Aarti Drug373.203,406.20
Aarti Pharma697.756,325.64
Abbott India25,785.0054,791.33
Accent Micro433.501,039.92

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
ICICI Prudent..199.853.18
HDFC Balanced..124.910.13
HDFC Flexi Ca..120.580.13
Invesco India..108.480.61
ICICI Prudent..101.570.18

Board Meetings

DatePurpose
12/02/2026Quarterly Results
12/11/2025Quarterly Results
13/08/2025Quarterly Results
28/05/2025Audited Results
12/02/2025Quarterly Results